- Home
- MTZ vs MEDP Comparison
MTZ vs MEDP Comparison
Compare MTZ & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTZ
- MEDP
- Stock Information
- Founded
- MTZ 1929
- MEDP 1992
- Country
- MTZ United States
- MEDP United States
- Employees
- MTZ 33000
- MEDP N/A
- Industry
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MTZ Industrials
- MEDP Health Care
- Exchange
- MTZ Nasdaq
- MEDP Nasdaq
- Market Cap
- MTZ 10.8B
- MEDP 11.7B
- IPO Year
- MTZ N/A
- MEDP 2016
- Fundamental
- Price
- MTZ $136.56
- MEDP $337.28
- Analyst Decision
- MTZ Strong Buy
- MEDP Buy
- Analyst Count
- MTZ 14
- MEDP 10
- Target Price
- MTZ $148.07
- MEDP $389.00
- AVG Volume (30 Days)
- MTZ 932.7K
- MEDP 272.3K
- Earning Date
- MTZ 10-31-2024
- MEDP 02-10-2025
- Dividend Yield
- MTZ N/A
- MEDP N/A
- EPS Growth
- MTZ N/A
- MEDP 33.84
- EPS
- MTZ 1.13
- MEDP 11.42
- Revenue
- MTZ $12,180,445,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- MTZ $2.91
- MEDP $14.01
- Revenue Next Year
- MTZ $8.87
- MEDP $5.86
- P/E Ratio
- MTZ $121.06
- MEDP $29.53
- Revenue Growth
- MTZ 3.89
- MEDP 16.24
- 52 Week Low
- MTZ $60.96
- MEDP $277.72
- 52 Week High
- MTZ $150.12
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- MTZ 49.22
- MEDP 47.55
- Support Level
- MTZ $129.88
- MEDP $326.92
- Resistance Level
- MTZ $139.65
- MEDP $359.49
- Average True Range (ATR)
- MTZ 4.81
- MEDP 10.74
- MACD
- MTZ -1.08
- MEDP -1.05
- Stochastic Oscillator
- MTZ 47.24
- MEDP 31.81
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include the engineering, building, installation, maintenance, and upgrade of communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five reportable segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.